Follow The Filings

NTRA Natera

Natera earnings company data as of 7:06 PM ET 10/30

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -0.28 — —
Rev $707.5M — —

Insider trades

Open-market buys and sales by NTRA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NTRA insider trades
  • None no insider bought on the open market
  • $49.4M sold by 4 insiders outside a trading plan
  • $282M sold by 10 insiders under 10b5-1 plans
  1. Michael Burkes Brophy CFO
    Planned sale
    $1.3M 3,084 shares at $425.90 6.2% of stake
    Traded Oct 28–30 Filed Oct 30
    ↗
  2. Jonathan Sheena Founder
    Planned sale
    $1.3M 3,150 shares at $410.55 1.4% of stake
    Traded Oct 21 Filed Oct 23
    ↗
  3. Jonathan Sheena Founder
    Planned sale
    $604K 1,500 shares at $402.47 15% of stake
    Traded Oct 16 Filed Oct 20
    ↗
  4. Matthew Rabinowitz Chair
    Planned sale
    $20.1M 50,000 shares at $402.64 2.3% of stake
    Traded Oct 15 Filed Oct 16
    ↗
  5. Solomon Moshkevich President, Clinicaldiagnostics
    Planned sale
    $1.2M 3,000 shares at $414.22 2.7% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  6. Steven Leonard Chapman CEO
    Planned sale
    $526K 1,273 shares at $413.31 1.3% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  7. Jonathan Sheena Founder
    Planned sale
    $7M 18,064 shares at $388.01 67% of stake
    Traded Sep 23 Filed Sep 25
    ↗
  8. Jonathan Sheena Founder
    Planned sale
    $3.2M 9,150 shares at $351.49 4% of stake
    Traded Sep 15–16 Filed Sep 17
    ↗
  9. Matthew Rabinowitz Chair
    Planned sale
    $34.8M 102,000 shares at $341.15
    Traded Sep 14–15 Filed Sep 16
    ↗
  10. Matthew Rabinowitz Chair
    Planned sale
    $16.4M 50,000 shares at $327.97 2.2% of stake
    Traded Sep 11 Filed Sep 11
    ↗
  11. Solomon Moshkevich President, Clinicaldiagnostics
    Planned sale
    $962K 3,000 shares at $320.73 2.3% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  12. Steven Leonard Chapman CEO
    Planned sale
    $545K 1,698 shares at $320.99 1.7% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  13. Jonathan Sheena Founder
    Planned sale
    $2M 6,000 shares at $325.32 2.5% of stake
    Traded Aug 10 Filed Aug 14
    ↗
  14. Jonathan Sheena Founder
    Planned sale
    $2.9M 9,150 shares at $315.66 3.7% of stake
    Traded Aug 7 Filed Aug 7
    ↗
  15. Matthew Rabinowitz Chair
    Planned sale
    $642K 2,000 shares at $320.90 50% of stake
    Traded Aug 7 Filed Aug 7
    ↗

Also filed in the last 12 months, not counted as buying or selling: 98 sales to cover taxes, 63 stock grants, 25 option exercises, 5 gifts, and 1 share withholding for taxes.

SEC filings

Recent issuer filings from EDGAR, 3 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 2 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.